Nasus Pharma Ltd. (NSRX)

Nasus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	69	-	-	-
Enterprise Value	72	-	-	-
Debt / Equity Ratio	-0.59	-0.56	-0.65	-0.56
Net Debt / Equity Ratio	-0.55	-0.47	-0.60	-0.51
Quick Ratio	0.04	0.10	0.05	0.05
Current Ratio	0.06	0.12	0.11	0.13
Return on Assets (ROA)	-106.39%	-116.06%	-166.52%	-
Return on Capital Employed (ROCE)	32.70%	33.60%	30.20%	73.30%
Buyback Yield / Dilution	-5.44%	0.43%	-2.44%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q